Overview

Cytokines and Chemokines in Erythema Migrans

Status:
Unknown status
Trial end date:
2020-12-31
Target enrollment:
Participant gender:
Summary
The main objective of this study is to characterize the inflammatory proteins, gene polymorphisms, and transcriptome profiles in patients with erythema migrans to gain better insight into pathogenesis of early Lyme borreliosis and to define new immune modulators that could serve as biomarkers of disease activity.
Phase:
N/A
Details
Lead Sponsor:
University Medical Centre Ljubljana
Collaborators:
Harvard University
Medical University of Vienna
University of Ljubljana School of Medicine, Slovenia
Treatments:
Anti-Bacterial Agents
Antibiotics, Antitubercular